Forget Cash ISAs. I’d buy these 2 FTSE 100 dividend stocks today for a passive income

I think these two FTSE 100 (INDEXFTSE:UKX) dividend stocks could offer robust passive incomes and long-term capital growth potential.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The FTSE 100’s market crash may cause some income investors to pivot from shares to other assets, such as Cash ISAs, when seeking to make a passive income. Cash ISAs offer far less risk than stocks. But their returns could be relatively unattractive in an era where low interest rates look set to remain in place.

As such, buying FTSE 100 shares that have the capacity to pay rising dividends over the coming years could be a sound move. Here are two prime examples of large-cap shares that could offer strong income returns, despite an uncertain global economic outlook.

FTSE 100 pharma stock AstraZeneca

The recent quarterly update from pharmaceutical company AstraZeneca (LSE: AZN) highlighted its growth credentials. The FTSE 100 business reported a 17% rise in its sales compared to the same period of the previous year. And its core earnings increased by 21%.

Further growth could be ahead for the business over the long run. It has invested heavily in its pipeline over recent years. And it has developed a relatively strong position in emerging economies such as China. This could allow it to sustain a high growth rate that merits an upward revaluation for its share price.

AstraZeneca also offers defensive characteristics. This could make it a relatively popular stock among income investors due to the ongoing risks facing the world economy. Its dividend yield currently stands at just 2.6%. But it could rise at a relatively brisk pace over the coming years as the company’s bottom line moves higher.

While there may be higher-yielding shares available in the FTSE 100, the dividend growth potential and defensive nature of AstraZeneca’s business model could make it a reliable means of producing a strong passive income in the coming years.

Imperial Brands

Imperial Brands (LSE: IMB) recently reported that coronavirus has not had a material impact on its financial performance. As such, the FTSE 100 stock could offer defensive appeal at a time when many companies are facing challenging financial outlooks.

Of course, Imperial Brands faces its own challenges at the present time. Falling cigarette volumes, disappointing growth rates for its next-generation products versus forecasts and a management shakeup could mean that the FTSE 100 former favourite displays a degree of volatility in the short run. Likewise, the company may seek to reduce its debt levels as per industry rivals. As part of this strategy, it recently disposed of its cigar business.

With a dividend yield of 12%, Imperial Brands is currently one of the highest-yielding shares in the FTSE 100. A management change may mean that there is scope for its dividend policy to be updated. But investors appear to have factored in a wide margin of safety into the company’s share price. As such, with a defensive business model and strong pricing power in its tobacco portfolio, Imperial Brands could offer a relatively robust passive income over the long run.

Peter Stephens owns shares of AstraZeneca and Imperial Brands. The Motley Fool UK has recommended Imperial Brands. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Storytelling image of a multiethnic senior couple in love - Elderly married couple dating outdoors, love emotions and feelings
Investing Articles

£10k invested in sizzling Barclays, Lloyds and NatWest shares 1 year ago is now worth…

Harvey Jones is blown away by the performance of NatWest shares and the other FTSE 100 banks over the last…

Read more »

Investing Articles

£5,000 invested in these 3 UK stocks at the start of 2025 is now worth…

Mark Hartley breaks down the growth of three UK stocks that helped drive the FTSE 100 to new highs this…

Read more »

Young Caucasian man making doubtful face at camera
Investing Articles

Time to start preparing for a stock market crash?

2025's been an uneven year on stock markets. This writer is not trying to time the next stock market crash…

Read more »

Santa Clara offices of NVIDIA
Investing Articles

Nvidia stock’s had a great 2025. Can it keep going?

Christopher Ruane sees an argument for Nvidia stock's positive momentum to continue -- and another for the share price to…

Read more »

Close-up of a woman holding modern polymer ten, twenty and fifty pound notes.
Investing Articles

£20,000 in savings? Here’s how someone could aim to turn that into a £10,958 annual second income!

Earning a second income doesn't necessarily mean doing more work. Christopher Ruane highlights one long-term approach based on owning dividend…

Read more »

Road 2025 to 2032 new year direction concept
Investing Articles

My favourite FTSE value stock falls another 6% on today’s results – should I buy more?

Harvey Jones highlights a FTSE 100 value stock that he used to consider boring, but has been surprisingly volatile lately.…

Read more »

UK supporters with flag
Investing Articles

See what £10,000 invested in the FTSE 100 at the start of 2025 is worth today…

Harvey Jones is thrilled by the stunning performance of the FTSE 100, but says he's having a lot more fun…

Read more »

Investing Articles

Prediction: here’s where the latest forecasts show the Vodafone share price going next

With the Vodafone turnaround strategy progressing, strong cash flow forecasts could be the key share price driver for the next…

Read more »